Controversies Surrounding Clostridium difficile Infection in Infants and Young Children

Maribeth R Nicholson1, Isaac P Thomsen2, Kathryn M Edwards3

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Vanderbilt University School of Medicine, 2200 Children's Way, Nashville TN 37232, USA. kathryn.edwards@vanderbilt.edu.

Insights

Clostridium difficile (C. difficile) colonization is common in infants but rarely causes illness, unlike in adults. This difference is likely due to infant gut factors, making treatment decisions for children challenging.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Gastroenterology

Background:

  • Clostridium difficile is a leading cause of antibiotic-associated diarrhea in adults and older children.
  • Infants exhibit high rates of asymptomatic Clostridium difficile colonization, with up to 80% affected.
  • The mechanisms underlying this protective colonization in infants remain unclear.

Purpose of the Study:

  • To investigate the reasons for asymptomatic Clostridium difficile colonization in infants.
  • To understand the factors contributing to the lower incidence of symptomatic disease in infants compared to older populations.
  • To aid in determining appropriate treatment strategies for children testing positive for C. difficile.

Main Methods:

  • The study likely involved analyzing differences in toxin receptor expression between infant and adult gut cells.
  • Investigating potential variations in toxin internalization mechanisms.
  • Reviewing clinical data on C. difficile detection rates and disease presentation in pediatric populations.

Main Results:

  • Infants may possess different toxin receptors or impaired toxin internalization processes, preventing symptomatic infection.
  • Increased detection rates and atypical disease presentations complicate clinical management in children.
  • Children without classic risk factors are increasingly presenting with C. difficile-associated disease.

Conclusions:

  • Differences in gut physiology, specifically toxin receptors or internalization, likely explain infant resistance to symptomatic C. difficile infection.
  • Clinical decision-making for treating C. difficile in children requires careful consideration due to diagnostic challenges and evolving risk factors.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.8K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.5K